×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateurs :
Guillaume Bataillon
Benoit You

 

Intervenants :
Stéphanie Nougaret
Guillaume Bataillon
Benoit You
Gwenaël Ferron

 

Agenda

18:00 Vision du radiologue de la carcinose
Stéphanie Nougaret
 
18:20 Vision de l'Anapath pour le CRS et IA
Guillaume Bataillon
 
18:40 Vision de l'oncologue
Benoit You
 
19:00 Vision du chirurgien pour le PCI, See2cure
Gwenaël Ferron
 
19:20 Débat/Discussion – Réponses aux questions
 

 

Shooting date : 2025-04-15
Last update : 2025-05-19
1 comment
Join the Discussion
  • Marianne P. marianne persyn
    14510012100

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Tuesday, October 18th 2022 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, October 18th 2022 from 06am to 07:30am (GMT+2)
    San Francisco : Tuesday, October 18th 2022 from 09am to 10:30am (GMT+2)
    New York : Tuesday, October 18th 2022 from 12pm to 01:30pm (GMT+2)
    Buenos Aires : Tuesday, October 18th 2022 from 01pm to 02:30pm (GMT+2)
    Reykjavik : Tuesday, October 18th 2022 from 04pm to 05:30pm (GMT+2)
    London / Dublin : Tuesday, October 18th 2022 from 05pm to 06:30pm (GMT+2)
    Paris / Berlin : Tuesday, October 18th 2022 from 06pm to 07:30pm (GMT+2)
    Istanbul : Tuesday, October 18th 2022 from 07pm to 08:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, October 18th 2022 from 08pm to 09:30pm (GMT+2)
    Bangkok : Tuesday, October 18th 2022 from 11pm to 12:30am (GMT+2)
    Shanghai : Wednesday, October 19th 2022 from 12am to 01:30am (GMT+2)
    Tokyo : Wednesday, October 19th 2022 from 01am to 02:30am (GMT+2)
    Sydney : Wednesday, October 19th 2022 from 03am to 04:30am (GMT+2)
    Wellington : Wednesday, October 19th 2022 from 05am to 06:30am (GMT+2)

    Evolution de la chirurgie du cancer de l’ovaire en 2022

    Share
    Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Monday, November 28th 2022 from 06am to 07:30am (GMT+1)
    San Francisco : Monday, November 28th 2022 from 08am to 09:30am (GMT+1)
    New York : Monday, November 28th 2022 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Monday, November 28th 2022 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Monday, November 28th 2022 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Monday, November 28th 2022 from 05pm to 06:30pm (GMT+1)
    Istanbul : Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Monday, November 28th 2022 from 08pm to 09:30pm (GMT+1)
    Bangkok : Monday, November 28th 2022 from 11pm to 12:30am (GMT+1)
    Shanghai : Tuesday, November 29th 2022 from 12am to 01:30am (GMT+1)
    Tokyo : Tuesday, November 29th 2022 from 01am to 02:30am (GMT+1)
    Sydney : Tuesday, November 29th 2022 from 02am to 03:30am (GMT+1)
    Wellington : Tuesday, November 29th 2022 from 04am to 05:30am (GMT+1)

    Prise en charge du cancer de l’ovaire avancé à l’ère de la médecine de précision en 2022

    Share
    Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, September 19th 2023 from 06am to 07:30am (GMT+2)
    San Francisco : Tuesday, September 19th 2023 from 09am to 10:30am (GMT+2)
    New York : Tuesday, September 19th 2023 from 12pm to 01:30pm (GMT+2)
    Buenos Aires : Tuesday, September 19th 2023 from 01pm to 02:30pm (GMT+2)
    Reykjavik : Tuesday, September 19th 2023 from 04pm to 05:30pm (GMT+2)
    London / Dublin : Tuesday, September 19th 2023 from 05pm to 06:30pm (GMT+2)
    Paris / Berlin : Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
    Istanbul : Tuesday, September 19th 2023 from 07pm to 08:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, September 19th 2023 from 08pm to 09:30pm (GMT+2)
    Bangkok : Tuesday, September 19th 2023 from 11pm to 12:30am (GMT+2)
    Shanghai : Wednesday, September 20th 2023 from 12am to 01:30am (GMT+2)
    Tokyo : Wednesday, September 20th 2023 from 01am to 02:30am (GMT+2)
    Sydney : Wednesday, September 20th 2023 from 03am to 04:30am (GMT+2)
    Wellington : Wednesday, September 20th 2023 from 05am to 06:30am (GMT+2)

    Prise en charge des carcinomes séreux de bas grade en 2023

    Share
    Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Tuesday, September 5th 2023 from 06:30am to 08am (GMT+2)
    San Francisco : Tuesday, September 5th 2023 from 09:30am to 11am (GMT+2)
    New York : Tuesday, September 5th 2023 from 12:30pm to 02pm (GMT+2)
    Buenos Aires : Tuesday, September 5th 2023 from 01:30pm to 03pm (GMT+2)
    Reykjavik : Tuesday, September 5th 2023 from 04:30pm to 06pm (GMT+2)
    London / Dublin : Tuesday, September 5th 2023 from 05:30pm to 07pm (GMT+2)
    Paris / Berlin : Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
    Istanbul : Tuesday, September 5th 2023 from 07:30pm to 09pm (GMT+2)
    Moscou / Dubaï : Tuesday, September 5th 2023 from 08:30pm to 10pm (GMT+2)
    Bangkok : Tuesday, September 5th 2023 from 11:30pm to 01am (GMT+2)
    Shanghai : Wednesday, September 6th 2023 from 12:30am to 02am (GMT+2)
    Tokyo : Wednesday, September 6th 2023 from 01:30am to 03am (GMT+2)
    Sydney : Wednesday, September 6th 2023 from 03:30am to 05am (GMT+2)
    Wellington : Wednesday, September 6th 2023 from 05:30am to 07am (GMT+2)

    Les nouveaux enjeux de la prise en charge du cancer de l’ovaire en première ligne : L’exemple d...

    Cycle d'enseignement sur le cancer de l'ovaire - Première session

    Share
    Scroll Up